Royal DSM N.V. has repurchased 518,451 of its own shares in the
period from 23 August 2007 up to and including 29 August 2007 at an
average price of EUR 37.09. This is in accordance with the second
phase of the share buyback program, announced on 27 April 2007. The
consideration of this repurchase was EUR 19.2 million.
The total number of shares repurchased under the second phase of this
program to date is 12,996,837 shares for a total consideration of EUR
477.0 million.
DSM
DSM is active worldwide in nutritional and pharma ingredients,
performance materials and industrial chemicals. The company develops,
produces and sells innovative products and services that help improve
the quality of life. DSM's products are used in a wide range of
end-markets and applications, such as human and animal nutrition and
health, personal care, pharmaceuticals, automotive and transport,
coatings and paint, housing and electrics & electronics (E&E). DSM's
strategy, named Vision 2010 - Building on Strengths, focuses on
accelerating profitable and innovative growth of the company's
specialties portfolio. The key drivers of this strategy are
market-driven growth and innovation plus an increased presence in
emerging economies. The group has annual sales of over ¤8 billion and
employs some 22,000 people worldwide. DSM ranks among the global
leaders in many of its fields. The company is headquartered in the
Netherlands, with locations in Europe, Asia, Africa, Australia and
the Americas. More information about DSM can be found at www.dsm.com.
For more information:
DSM Corporate Communications DSM Investor Relations
Elvira Luykx Dries Ausems
tel. +31 (0) 45 tel. +31 (0) 45 5782864
5782035 fax +31 (0) 45 5782595
fax +31 (0) 45 e-mail
5740680 investor.relations@dsm.com
e-mail media.relations@dsm.com
